WO_x Nanosheets Enhance Acute Kidney Injury Therapy Through Geometry-Improved Targeting and Antioxidant Properties

Abstract

Ultra-small nanoparticles, nanowires, and two-dimensional nanosheets have attracted much attention in acute kidney injury (AKI) treatment. However, the influence of nanostructure geometry on AKI therapy remains unknown. It is important to investigate their biodistribution, clearance, and toxicology to identify the most potential geometry for further nanomedical applications. Herein, three types of oxygen-deficient tungsten oxide (WO_x) nanostructures, nanodots, nanowires, and nanosheets, with attractive reactive oxygen species (ROS) scavenging and computed tomography (CT) imaging properties are bottom-up synthesized, and their in vivo behaviors are systematically studied. The biodistribution results demonstrate that all three WO_x nanostructures can penetrate from the kidney and excrete to the bladder. Interestingly, nanodots can accumulate and be cleared quickly from the kidney, while nanosheets have long retention in vivo. In marked contrast to nanodots and nanosheets, nanowires show high levels in the lung organs with significant cytotoxicity. Therapeutic experiments suggest that nanodots and nanosheets have better therapeutic effects on AKI, but the therapeutic effect of nanowires is not obvious. Furthermore, the nanosheets perform better in alleviating AKI at a lower injection dose than nanodots. This work demonstrates that nanosheets, among various geometries, have particular potential for further AKI treatment because of outstanding performance in CT imaging, renal targeting, long-time retention, and low toxicity. The “structure-function” correlations enable the reasonable design of nanoprobes for AKI theragnostic.

Keywords

acute kidney injury / biodistribution / CT imaging / ROS elimination / WO_x nanostructures

References

[1] S. L. Goldstein and P. Devarajan, “Acute Kidney Injury Leads to Pediatric Patient Mortality,” Nature Reviews Nephrology 6 (2010): 393-394.

[2] S. J. Allison, “Propagation of Acute Kidney Injury,” Nature Reviews Nephrology 19 (2023): 622-622.

[3] R. Bellomo, “Acute Kidney Injury—A Decade of Progress,” Nature Reviews Nephrology 11 (2015): 636-637.

[4] G. S. A. Varshan and S. K. R. Namasivayam, “A Critical Review on Sustainable Formulation of Anti-Quorum Sensing Compounds Using Nanotechnology Principles Against Candida Albicans,” BioNanoScience 15 (2025): 161.

[5] K. S. Sivasuriyan, S. K. R. Namasivayam, and A. Pandian, “Molecular Insights Into the Anti-Cancer Activity of Chitosan-Okra Mucilage Polymeric Nanocomposite Doped With Nano Zero-Valent Iron Against Multi-Drug-Resistant Oral Carcinoma Cells,” International Journal of Biological Macromolecules 286 (2025): 138495.

[6] A. L. Francis, S. K. R. Namasivayam, and K. Samrat, “Potential of Silver Nanoparticles Synthesized From Justicia adhatoda Metabolites for Inhibiting Biofilm on Urinary Catheters,” Microbial Pathogenesis 196 (2024): 106957.

[7] R. Sowmya, S. Karthick Raja Namasivayam, and S. Krithika Shree, “A Critical Review on Nano-Selenium Based Materials: Synthesis, Biomedicine Applications and Biocompatibility Assessment,” Journal of Inorganic and Organometallic Polymers and Materials 34 (2024): 3037-3055.

[8] D. Jiang, Z. T. Rosenkrans, D. Ni, J. Lin, P. Huang, and W. Cai, “Nanomedicines for Renal Management: From Imaging to Treatment,” Accounts of Chemical Research 53 (2020): 1869-1880.

[9] A. Jakhmola, N. Anton, H. Anton, et al., “Poly-ε-Caprolactone Tungsten Oxide Nanoparticles as a Contrast Agent for X-ray Computed Tomography,” Biomaterials 35 (2014): 2981-2986.

[10] Z. Zhu, X. Chen, H. Liao, et al., “Microalbuminuria Sensitive Near-Infrared AIE Probe for Point-of-Care Evaluating Kidney Diseases,” Aggregate 5 (2024): e526.

[11] H. Xu, X. Chen, H. Wang, et al., “Utilization of Aggregation-Induced Emission Materials in Urinary System Diseases,” Aggregate 5 (2024): e580.

[12] Y. Zhao, M. Pu, Y. Wang, L. Yu, X. Song, and Z. He, “Application of Nanotechnology in Acute Kidney Injury: From Diagnosis to Therapeutic Implications,” Journal of Controlled Release 336 (2021): 233-251.

[13] L. Guo, H. Yan, Q. Gong, et al., “Glomerulus-Targeted ROS-Responsive Polymeric Nanoparticles for Effective Membranous Nephropathy Therapy,” ACS Applied Materials & Interfaces 16 (2024): 35447-35462.

[14] J. E. Zuckerman, C. H. Choi, H. Han, and M. E. Davis, “Polycation-siRNA Nanoparticles Can Disassemble at the Kidney Glomerular Basement Membrane,” Proceedings of the National Academy of Sciences of the United States of America 109 (2012): 3137-3142.

[15] Y. Wang, Q. Wu, J. Wang, et al., “Co-Delivery of p38α MAPK and p65 siRNA by Novel Liposomal Glomerulus-Targeting Nano Carriers for Effective Immunoglobulin a Nephropathy Treatment,” Journal of Controlled Release 320 (2020): 457-468.

[16] A. Chrastina, K. A. Massey, and J. E. Schnitzer, “Overcoming In Vivo Barriers to Targeted Nanodelivery,” Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 3 (2011): 421-437.

[17] K. Pombo Garcia, K. Zarschler, L. Barbaro, et al., “Zwitterionic-Coated “Stealth” Nanoparticles for Biomedical Applications: Recent Advances in Countering Biomolecular Corona Formation and Uptake by the Mononuclear Phagocyte System,” Small 10 (2014): 2516-2529.

[18] J. Wang, J. D. Byrne, M. E. Napier, and J. M. DeSimone, “More Effective Nanomedicines Through Particle Design,” Small 7 (2011): 1919-1931.

[19] P. Cheng and K. Pu, “Molecular Imaging and Disease Theranostics With Renal-Clearable Optical Agents,” Nature Reviews Materials 6 (2021): 1095-1113.

[20] N. Kamaly, J. C. He, D. A. Ausiello, and O. C. Farokhzad, “Nanomedicines for Renal Disease: Current Status and Future Applications,” Nature Reviews Nephrology 12 (2016): 738-753.

[21] J. Wang and G. Liu, “Imaging Nano-Bio Interactions in the Kidney: Toward a Better Understanding of Nanoparticle Clearance,” Angewandte Chemie International Edition 57 (2018): 3008-3010.

[22] K. He, Y.-F. Ding, Z. Zhao, et al., “Cucurbit[7]Uril-Mediated Organ-Specific Delivery of Ultrasmall NIR-II Luminescent Gold Nanocarriers for Therapy of Acute Kidney Injury,” Advanced Functional Materials 34 (2024): 2309949.

[23] S. He, C. Chen, F. Li, et al., “A Polymeric Nanosponge as a Broad-Spectrum Reactive Oxygen Species Scavenger for Acute Kidney Injury Treatment,” Nano Letters 23 (2023): 8978-8987.

[24] W. Huang, L. Wen, H. Tian, et al., “Self-Propelled Proteomotors With Active Cell-Free mtDNA Clearance for Enhanced Therapy of Sepsis-Associated Acute Lung Injury,” Advanced Science 10 (2023): 2301635.

[25] Y. Li, G. Wang, T. Wang, et al., “PEGylated Gambogic Acid Nanoparticles Enable Efficient Renal-Targeted Treatment of Acute Kidney Injury,” Nano Letters 23 (2023): 5641-5647.

[26] H. Yu, F. Jin, D. Liu, et al., “ROS-Responsive Nano-Drug Delivery System Combining Mitochondria-Targeting Ceria Nanoparticles With Atorvastatin for Acute Kidney Injury,” Theranostics 10 (2020): 2342-2357.

[27] Q. Weng, H. Sun, C. Fang, et al., “Catalytic Activity Tunable Ceria Nanoparticles Prevent Chemotherapy-Induced Acute Kidney Injury Without Interference With Chemotherapeutics,” Nature Communications 12 (2021): 1436.

[28] B. Du, M. Yu, and J. Zheng, “Transport and Interactions of Nanoparticles in the Kidneys,” Nature Reviews Materials 3 (2018): 358-374.

[29] R. Duan, Y. Li, R. Zhang, et al., “Reversing Acute Kidney Injury Through Coordinated Interplay of Anti-Inflammation and Iron Supplementation,” Advanced Materials 35 (2023): 2301283.

[30] T. Liu, B. Xiao, F. Xiang, et al., “Ultrasmall Copper-Based Nanoparticles for Reactive Oxygen Species Scavenging and Alleviation of Inflammation Related Diseases,” Nature Communications 11 (2020): 2788.

[31] D. Ni, D. Jiang, C. J. Kutyreff, et al., “Molybdenum-Based Nanoclusters Act as Antioxidants and Ameliorate Acute Kidney Injury in Mice,” Nature Communications 9 (2018): 5421.

[32] D.-Y. Zhang, T. Tu, M. R. Younis, et al., “Clinically Translatable Gold Nanozymes With Broad Spectrum Antioxidant and Anti-Inflammatory Activity for Alleviating Acute Kidney Injury,” Theranostics 11 (2021): 9904-9917.

[33] T. Sun, D. Jiang, Z. T. Rosenkrans, et al., “A Melanin-Based Natural Antioxidant Defense Nanosystem for Theranostic Application in Acute Kidney Injury,” Advanced Functional Materials 29 (2019): 1904833.

[34] S. Madesh, S. Palaniappan, A. Aravind, et al., “Mitigation of Gentamycin Induced Acute Kidney Injury due to Benzothiazole Derivatives N1 and N5: Antioxidant and Renoprotective Mechanisms In-Vivo Zebrafish,” Toxicology Letters 405 (2025): 30-40.

[35] S. Wu, F. Nan, K. Zhang, et al., “A Novel Metal-Organic Framework Encapsulated Iridium Oxide Nanozyme Enhanced Antisense Oligonucleotide Combo for Osteoarthritis Synergistic Therapy,” Aggregate 5 (2024): e635.

[36] A. Ruggiero, C. H. Villa, E. Bander, et al., “Paradoxical Glomerular Filtration of Carbon Nanotubes,” Proceedings of the National Academy of Sciences of the United States of America 107 (2010): 12369-12374.

[37] S. Alidori, N. Akhavein, D. L. J. Thorek, et al., “Targeted Fibrillar Nanocarbon RNAi Treatment of Acute Kidney Injury,” Science Translational Medicine 8 (2016): 331ra339-331ra339.

[38] L. Lacerda, A. Soundararajan, R. Singh, et al., “Dynamic Imaging of Functionalized Multi-Walled Carbon Nanotube Systemic Circulation and Urinary Excretion,” Advanced Materials 20 (2007): 225-230.

[39] J. Hou, H. Wang, Z. Ge, et al., “Treating Acute Kidney Injury With Antioxidative Black Phosphorus Nanosheets,” Nano Letters 20 (2020): 1447-1454.

[40] Q. Chen, F. Ding, S. Zhang, et al., “Sequential Therapy of Acute Kidney Injury With a DNA Nanodevice,” Nano Letters 21 (2021): 4394-4402.

[41] D. Jiang, Z. Ge, H.-J. Im, et al., “DNA Origami Nanostructures Can Exhibit Preferential Renal Uptake and Alleviate Acute Kidney Injury,” Nature Biomedical Engineering 2 (2018): 865-877.

[42] W. Li, C. Wang, H. Lv, et al., “A DNA Nanoraft-Based Cytokine Delivery Platform for Alleviation of Acute Kidney Injury,” ACS Nano 15 (2021): 18237-18249.

[43] X. Zhao, L.-Y. Wang, J.-M. Li, et al., “Redox-Mediated Artificial Non-Enzymatic Antioxidant MXene Nanoplatforms for Acute Kidney Injury Alleviation,” Advanced Science 8 (2021): 2101498.

[44] J. Lee, S. Choi, K. H. Kim, et al., “Nontoxic Formulations of Scintillation Nanocrystals for Use as X-Ray Computed Tomography Contrast Agents,” Bioconjugate Chemistry 28 (2017): 171-182.

[45] L. Cheng, C. Yuan, S. Shen, et al., “Bottom-Up Synthesis of Metal-Ion-Doped WS 2 Nanoflakes for Cancer Theranostics,” ACS Nano 9 (2015): 11090-11101.

[46] J. Qiu, Q. Xiao, X. Zheng, et al., “Single W18O49 Nanowires: A Multifunctional Nanoplatform for Computed Tomography Imaging and Photothermal/Photodynamic/Radiation Synergistic Cancer Therapy,” Nano Research 8 (2015): 3580-3590.

[47] N. Zhang, X. Li, H. Ye, et al., “Oxide Defect Engineering Enables to Couple Solar Energy Into Oxygen Activation,” Journal of the American Chemical Society 138 (2016): 8928-8935.

[48] J. Ouyang, S. Rao, R. Liu, et al., “2D Materials-Based Nanomedicine: From Discovery to Applications,” Advanced Drug Delivery Reviews 185 (2022): 114268.

[49] Y. Cheng, F. Yang, G. Xiang, et al., “Ultrathin Tellurium Oxide/Ammonium Tungsten Bronze Nanoribbon for Multimodality Imaging and Second Near-Infrared Region Photothermal Therapy,” Nano Letters 19 (2019): 1179-1189.

[50] Y. T. Qi, F. L. Zhang, S. Y. Tian, et al., “Nanosensor Detection of Reactive Oxygen and Nitrogen Species Leakage in Frustrated Phagocytosis of Nanofibres,” Nature Nanotechnology 19 (2024): 524-533.

[51] T. Padmore, C. Stark, L. A. Turkevich, and J. A. Champion, “Quantitative Analysis of the Role of Fiber Length on Phagocytosis and Inflammatory Response by Alveolar Macrophages,” BBA-GEN SUBJECTS 1861 (2017): 58-67.

[52] C. A. Poland, R. Duffin, I. Kinloch, et al., “Carbon Nanotubes Introduced Into the Abdominal Cavity of Mice Show Asbestos-Like Pathogenicity in a Pilot Study,” Nature Nanotechnology 3 (2008): 423-428.

[53] N. Saito, H. Haniu, Y. Usui, et al., “Safe Clinical Use of Carbon Nanotubes as Innovative Biomaterials,” Chemical Reviews 114 (2014): 6040-6079.

[54] M. J. Morgan and Z. G. Liu, “Crosstalk of Reactive Oxygen Species and NF-κB Signaling,” Cell Research 21 (2011): 103-115.

RIGHTS & PERMISSIONS

2025 The Author(s). Aggregate published by SCUT, AIEI, and John Wiley & Sons Australia, Ltd.